re: Ann: Omacetaxine European rights licensed... The news is hitting the presshttp://news.theage.com.au/breaking-news-business/chemgenex-in-licensing-deal-with-hospira-20091214-kqy0.html
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint